Key points are not available for this paper at this time.
Design
Review
Highlights potential therapeutic targets in cardiovascular disease; leaves open need for prospective clinical validation.
Numerous reports have indicated that the plasma concentration of endogenously produced inhibitors of nitric oxide synthase are elevated in human disease states. In this review we discuss recent advances in our understanding of the enzymes responsible for the synthesis of these inhibitors.
No takes yet. Share an insight, caveat, or question.
Anthony et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: